Hermetica Superfood Encyclopedia
The Short Answer
Vete (Marsdenia ochracea) belongs to a genus characterized by C21 steroidal glycosides, alkaloids, and terpenoids that, in closely related species, modulate apoptotic pathways and inhibit microbial growth. No direct clinical trials exist for M. ochracea itself, but its Samoan traditional use as a topical latex wound treatment aligns with the genus-wide antimicrobial and anti-inflammatory activities observed preclinically in congeners such as M. tenacissima and M. macrantha.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordVete Marsdenia ochracea benefits
Vete — botanical close-up
Health Benefits
**Wound Healing (Traditional)**: The milky latex of M
ochracea is applied topically to wounds in Samoan ethnomedicine, a practice consistent with the genus-wide presence of terpenoids and steroidal glycosides that demonstrate anti-inflammatory and antimicrobial properties in related species. No controlled clinical studies have validated this application specifically for M. ochracea.
**Antimicrobial Activity (Genus-Level Evidence)**: Extracts from congener M
macrantha inhibited Salmonella typhi with an inhibition zone of 19.7 ± 0.3 mm, attributable to flavonoids, alkaloids, and terpenoids disrupting bacterial cell function. Similar phytochemical classes are expected in M. ochracea based on chemotaxonomic patterns within Marsdenia.
**Anti-inflammatory Potential**
Steroidal glycosides present in Marsdenia species modulate inflammatory signaling pathways, and M. tenacissima extracts have demonstrated suppression of pro-inflammatory cytokine cascades in preclinical models. These properties provide a mechanistic rationale for the traditional wound-care use of M. ochracea latex.
**Antioxidant Properties**: Flavonoids identified in high concentrations in M
macrantha methanol extracts (yield 13.95 ± 0.41%) are well-established free-radical scavengers that reduce oxidative damage to tissues. Antioxidant activity may contribute to the wound-healing efficacy of topically applied latex from related Marsdenia species.
**Potential Anticancer Activity (Genus-Level)**: In M
tenacissima, extract at 5 g/kg orally reduced tumor growth in HCC827/ER xenograft mouse models by reversing multidrug resistance through modulation of PI3K/AKT/mTOR, ERK1/2, P-gp, and Axl signaling pathways. Whether M. ochracea shares this activity is unconfirmed and requires direct phytochemical and pharmacological investigation.
**Apoptosis Induction (Genus-Level)**
Marsdenia tenacissima extract induced apoptosis in human umbilical vein endothelial cells (HUVECs) at 160 μL/L (P < 0.001) via a PKCδ-induced, p53-dependent mitochondrial pathway involving upregulation of Bax and activation of caspase-3. This mechanism is driven by C21 steroidal glycosides that are characteristic of the broader Marsdenia genus.
Origin & History
Natural habitat
Marsdenia ochracea is a flowering vine in the family Apocynaceae (subfamily Asclepiadoideae), native to the Pacific Islands region including Samoa, where it grows in tropical forest margins and disturbed vegetation. The plant produces a milky latex characteristic of the genus, which is the primary medicinally utilized substance in traditional Samoan practice. Cultivation is non-commercial and the plant is harvested from wild populations; no dedicated agricultural production has been documented.
“In Samoa, Vete (M. ochracea) is documented in ethnobotanical surveys as a plant whose latex is used for wound treatment, representing an integration of locally available botanical resources into traditional healing practices that predate Western medicine in the Pacific Islands. The broader Marsdenia genus has a well-documented history in Traditional Chinese Medicine, where M. tenacissima stems (known as 'Tong Guan Teng') have been used for centuries as antitumor, anti-inflammatory, analgesic, and anti-arthritic remedies, suggesting a pan-regional recognition of the medicinal value of Marsdenia latex and tissue extracts. Samoan traditional medicine ('vaifofo') characteristically employs plant-derived topical preparations for wound care, infection prevention, and skin disorders, and the use of M. ochracea latex fits within this established therapeutic framework. Formal ethnopharmacological documentation of M. ochracea in Samoa remains sparse, and the species has not attracted the same level of systematic ethnobotanical study as Marsdenia species used in East and South Asian traditional medicine systems.”Traditional Medicine
Scientific Research
The scientific evidence base for M. ochracea specifically is essentially absent, with no peer-reviewed studies identified that characterize its phytochemistry, pharmacology, or clinical efficacy directly. Evidence for the Marsdenia genus derives from preclinical in vitro and in vivo studies: M. tenacissima extract reversed multidrug resistance in HCC827/ER lung cancer cell lines across a concentration range of 0.5–500 mg/mL, and reduced tumor growth in xenograft mouse models at 5 g/kg oral dosing, while M. macrantha extracts demonstrated statistically significant antibacterial activity (F-ratio = 326.71, p < 0.0003 across solvent systems). No human clinical trials have been conducted for any Marsdenia species, making all biomedical claims for M. ochracea highly extrapolated and the overall evidence quality low; the traditional Samoan wound-care application remains ethnobotanically documented but pharmacologically unvalidated.
Preparation & Dosage
Traditional preparation
**Traditional Topical Latex**
Fresh latex is collected directly from the cut stems or leaves of M. ochracea and applied to wounds as a topical agent per Samoan traditional practice; no standardized dose or application frequency has been documented.
**Preclinical Aqueous Extract (Genus Reference)**
Water extracts of M. macrantha yielded 10.92 ± 0.11% extractable matter via maceration; used at unspecified concentrations in antimicrobial assays only.
**Preclinical Methanol Extract (Genus Reference)**
Methanol Soxhlet extraction of M. macrantha achieved the highest yield (13.95 ± 0.41%); concentrations used in antibacterial disk-diffusion assays were not translated to human-equivalent doses.
**In Vivo Mouse Dose (Genus Reference, M. tenacissima)**
5 g/kg orally or by injection in xenograft mouse models; this dose has no established human equivalent and should not be used as a supplementation guideline
**In Vitro Monomer Dose (Genus Reference)**
Tenacigenin D active at 10–20 μM in cell culture; no bioavailability or human dosing correlation established.
**Standardization**
No commercial standardized extracts of M. ochracea or preparations standardized to specific steroidal glycoside content are available.
Nutritional Profile
Marsdenia ochracea has not been subjected to nutritional proximate analysis, and no macronutrient, micronutrient, or quantitative phytochemical data are available for the species itself. Based on genus-level phytochemical screening of M. macrantha, key bioactive classes include flavonoids (detected at high concentrations in methanol extracts), alkaloids (low concentrations), and terpenoids; C21 steroidal glycosides including tenacissimoside-type compounds and tenacigenins are the signature phytochemicals of the Marsdenia genus identified across approximately 196 discrete chemical constituents in M. tenacissima. The latex specifically, which is the traditionally used portion of M. ochracea, is expected to contain a complex mixture of polyisoprene (rubber-type) polymers, resinous compounds, steroidal components, and proteinaceous material characteristic of Apocynaceae family latices, though no compositional analysis has been published. Bioavailability of steroidal glycosides from oral consumption of related species is presumed to be moderate based on their polar glycoside structure, but no pharmacokinetic data exist for topically applied M. ochracea latex.
How It Works
Mechanism of Action
In closely related Marsdenia species, C21 steroidal glycosides such as tenacissimoside A and tenacigenin D are the primary drivers of bioactivity, with tenacigenin D (10–20 μM) modulating multidrug resistance in H460 lung cancer cells by downregulating P-glycoprotein and inhibiting PI3K/AKT/mTOR and ERK1/2 signaling cascades. Marsdenia tenacissima extract suppresses tumor angiogenesis by attenuating VEGF/VEGFR-2 interactions, downregulating VEGFR-2, P2Y6R, and CCL-2 expression on endothelial cells, thereby arresting their proliferation at S-phase. Antimicrobial effects documented in M. macrantha are attributed to flavonoids, alkaloids, and terpenoids that disrupt bacterial membrane integrity and inhibit essential enzymatic pathways in pathogens including S. typhi. No molecular mechanism data are directly available for M. ochracea, and the above pathways are extrapolated from genus-level evidence pending species-specific pharmacological characterization.
Clinical Evidence
No clinical trials have been conducted for Marsdenia ochracea, and no human intervention studies exist for any species within the Marsdenia genus as of the available literature. Preclinical studies for congeners are limited to in vitro cell-line experiments and mouse xenograft models, which represent the lowest tiers of translational evidence. The most quantified preclinical outcome is a statistically significant reduction in tumor growth in HCC827/ER xenograft mice at 5 g/kg M. tenacissima extract, alongside in vitro apoptosis induction at P < 0.001 in HUVECs; neither outcome can be confidently extrapolated to M. ochracea or to human populations. Confidence in any therapeutic claim for Vete remains very low, and formal ethnobotanical documentation of Samoan wound-care use constitutes the most robust evidence currently available.
Safety & Interactions
No clinical safety data, toxicology studies, or adverse event reports are available for Marsdenia ochracea, and formal risk characterization is not possible based on current literature. In preclinical mouse studies with the congener M. tenacissima, no overt toxicity was reported at doses up to 5 g/kg, but this finding cannot be directly transposed to M. ochracea or to human use, and the presence of C21 steroidal glycosides raises theoretical concerns about hormonal axis disruption with prolonged systemic exposure. The latex of Apocynaceae family plants can cause skin irritation, allergic contact dermatitis, or cytotoxic effects in sensitive individuals when applied topically, and individuals with known latex allergies or sensitive skin should exercise caution. No drug interaction data exist; however, given the genus-level evidence of P-glycoprotein modulation and PI3K/AKT/mTOR pathway interference in related species, potential pharmacokinetic interactions with chemotherapeutic agents, immunosuppressants, or anticoagulants cannot be excluded. Use during pregnancy and lactation is not recommended due to the complete absence of safety data and the theoretical risk posed by steroidal constituents.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Marsdenia ochraceaVete (Samoan)Apocynaceae vinePacific Marsdenia
Frequently Asked Questions
What is Vete used for in Samoan traditional medicine?
In Samoan traditional medicine, Vete (Marsdenia ochracea) is used primarily for its latex, which is applied topically to wounds as a healing agent. This application is consistent with the broader antimicrobial and anti-inflammatory properties documented preclinically in closely related Marsdenia species, though no controlled clinical studies have validated the wound-healing efficacy of M. ochracea latex specifically.
Is there scientific evidence supporting the medicinal use of Marsdenia ochracea?
Direct scientific evidence for Marsdenia ochracea is essentially absent, with no peer-reviewed phytochemical, pharmacological, or clinical studies published specifically for this species. Evidence is instead extrapolated from related species including M. tenacissima and M. macrantha, which have demonstrated antimicrobial, anti-inflammatory, and anticancer activities in preclinical in vitro and mouse models, but no human clinical trials have been completed for any Marsdenia species.
What bioactive compounds are found in Marsdenia species related to Vete?
The principal bioactive compounds in the Marsdenia genus are C21 steroidal glycosides, including tenacissimoside A, tenacigenin D, and 11α-O-benzoyl-12β-O-acetyltenacigenin B, primarily concentrated in stems and roots. Additional constituents include flavonoids (found in high concentrations in M. macrantha methanol extracts at 13.95 ± 0.41% yield), alkaloids, terpenoids, and saponins; approximately 196 chemical ingredients have been catalogued in M. tenacissima alone.
Is Vete latex safe to apply to the skin?
No formal safety or toxicology data exist for Marsdenia ochracea latex applied topically. Latices from the Apocynaceae plant family can cause contact dermatitis, skin irritation, or allergic reactions in some individuals, and those with latex sensitivities should exercise particular caution. Until species-specific safety studies are conducted, use should be limited to traditional practice contexts and avoided in individuals with known plant latex allergies or compromised skin integrity.
How does Marsdenia differ from other wound-healing plants in the Pacific Islands?
Marsdenia ochracea is distinctive in the Pacific Islands ethnobotanical context for its use of latex—a viscous, protein- and terpenoid-rich exudate—rather than leaf poultices or aqueous decoctions more commonly employed by regional wound-care plants. The latex delivery mechanism provides a physical occlusive barrier alongside its putative bioactive compounds, a combination not typical of most Pacific botanical wound treatments such as the leaf-based preparations used with Morinda citrifolia (Noni) or Hibiscus species. However, comparative efficacy studies between M. ochracea and other Pacific wound-care plants have not been conducted.
Is Vete (Marsdenia ochracea) safe to use during pregnancy or while breastfeeding?
There is insufficient clinical data on the safety of Marsdenia ochracea during pregnancy or lactation, and traditional topical use has not been formally evaluated in pregnant or nursing populations. Given the presence of steroidal glycosides and terpenoids in the plant, pregnant and breastfeeding women should consult a healthcare provider before use. No adverse events have been formally documented, but the lack of safety studies warrants caution.
What is the difference between Vete latex and other traditional Pacific Island wound remedies in terms of active compounds?
Unlike many Pacific wound-healing plants that rely primarily on tannins or alkaloids, Vete's milky latex is characterized by terpenoids and steroidal glycosides that provide both anti-inflammatory and antimicrobial effects simultaneously. This dual-action chemical profile is shared with other Marsdenia species but distinguishes Vete from plants like Calophyllum inophyllum (tamanu), which primarily delivers its benefits through fatty acids and polyphenols. The latex form of delivery also allows for direct, undigested application to affected tissue.
Are there known drug interactions between Vete and common medications?
No formal drug interaction studies have been conducted on Marsdenia ochracea with pharmaceutical medications. Because the plant contains steroidal glycosides that may influence inflammatory pathways, individuals taking immunosuppressants, corticosteroids, or anticoagulants should inform their healthcare provider before topical use. Topical application typically poses lower systemic absorption risk than oral supplements, but personalized medical advice is recommended for those on chronic medication regimens.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w vete-marsdenia-ochracea curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
